Novel lactococcus garvieae bacteriophage lac-gap-1 and use thereof in suppressing proliferation of lactococcus garvieae bacteria
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Sang Hyeon Kang, Soo Youn Jun, An Sung Kwon, Soon Hye Hwang
Life of this patent
Estimating the term…
Abstract
The present invention relates to a Myoviridae bacteriophage Lac-GAP-1 that is isolated from the nature and can kill specifically Lactococcus garvieae cells, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12686BP), and a method for preventing and treating the infections of Lactococcus garvieae using the composition comprising said bacteriophage as an active ingredient.
Claims5
A Myoviridae bacteriophage Lac-GAP-1 that is isolated from the nature and can kill Lactococcus garvieae cells specifically, which has the genome represented by the nucleotide sequence of SEQ. ID. NO:
- 1.
Dependencies are inferred from the claim text.